← Back to patent-cliff list
缬沙坦
Tier C — Watch / tradeValsartan
诺华制药
Originator
1996
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：AT1
Brand：Kalpress、Valpression、Varexan、Provas、Vals、Tareg、Diovan、代文、Nisis、Miten
Indications (approved)：左心室功能不全、高血压
Regional status
US
批准上市
1996-12-23
EU
无进展
2002-12-01
China
批准上市
2000-01-01
Japan
批准上市
2000-09-22
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Valsartan?
Approved indications include: 左心室功能不全, 高血压.
When does the Valsartan patent expire?
No public expiry year is available for Valsartan yet; this page updates once verified.
How do I get a quote for Valsartan intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25